APP Archives - Page 6 of 10 - Blue Horseshoe Stocks

Blue Horseshoe Stocks: AVOP, PBR, FRMC, UTRM

AV1 Group, Inc. AVOP
–
First thing’s first; we want to congratulate anyone that caught AVOP off of yesterday’s Extended Watchlist. Marijuana-related news strikes again! The stock traded as low as .0006 early in the morning, and would go on to push as high as .0015 just prior to the close.

–

That was good for an intraday run of 150% from this play on the heels of a press release stating that the company had been the subject of a friendly takeover by the Marijuana Incubator Group, which specializes in cultivation technology. We’ll definitely be following along with this story moving forward.

Petroleo Brasiliero S.A. (Petrobras) PBR

Yesterday we saw PBR make its first big consolidation since we began tracking its recovery off of all-time lows, but not before gapping up to a new high. It provides a good lesson as to why it’s always a good idea to sell into a gap-up and lock in those profits on strength.

Despite the dip, yesterday’s low of 13.70 is still significantly higher than its 11.25 price when we first came across the play on 03/21. We’d like to see support hold at or above that 13.70-mark, or risk seeing a more substantial pullback. Below that, the next level of support is the 200DMA at 13.47.

Overall, PBR and its options chain has exceeded our expectations at every turn, and provided it holds the level of support we just mentioned, we still like the May $12, and April $14 Calls for longer-term chances, and the $13.50 and $14 Weekly Calls for possible short-term opportunities.

Formcap Corp. FRMC

One of the potential bottom-plays we put forth in yesterday’s morning report went on to have quite a session. FRMC traded in a range from .031-.0489, representing a positive intraday move of 58%

It also marked the third consecutive session of the stock making both higher lows and higher highs, further confirming the uptrend off of its recent bottom.

United Treatment Centers, Inc. UTRM

We also want to point out one of our recent interests with fresh news hitting the wires this morning. We’ve been expecting an update from UTRM and it’s finally arrived:

LOS ANGELES, CA–(Marketwired – Apr 9, 2014) – United Treatment Centers Inc. (OTC Pink: UTRM) (PINKSHEETS: UTRM) DBA www.PotNetwork.tv: “We have closed our first round of financing and will launch full scale website/video operations on 4/20/2014. After fielding several offers, we have put together a structure that enhances shareholder value and is commensurate with our long term objectives” >> FULL PR

Speaking of marijuana-related plays, we will be re-alerting one of our old favorites tomorrow, be sure not to miss out on Thursday’s report hitting your inboxes between 9-9:30AM! This stock is primed with the potential for a serious move, so stay tuned!

Extended Watchlist:
JRCC, SNMX, MNGA, ZGNX, APP

OXBT, CETV, APP, CYBK & Extended Watchlist

Oxygen Biotherapeutics, Inc. OXBT
–
After appearing on our extended watchlist yesterday morning, OXBT had a monster session. The stock was a juggernaut, rising all day from its low of 1.70, up as high as 2.87, good for an intraday gain of 69% on more than 48X 3mo. average volume.

This came on the heels of a press release, included below:

MORRISVILLE, N.C. & CHESTER, N.J.–(BUSINESS WIRE)–Phyxius Pharma, Inc. and Oxygen Biotherapeutics, Inc., (OXBT), today announced that researchers at the Duke Clinical Research Institute (DCRI), part of the Duke University School of Medicine, recently published findings of a meta-analysis of multiple clinical trials that evaluated the use of levosimendan in patients undergoing heart surgery. The study aggregated and analyzed results from 14 independent clinical trials with a total of 1,155 patients. The published results showed that levosimendan was associated with reduced mortality (death) and other adverse outcomes including heart attacks during and after operation in patients with reduced heart function undergoing heart surgery. >> FULL PR

Central European Media Enterprises, Inc. CETV

We first alerted CETV back on May 10th, as popped up on one of our Form-4 scans. At the time, the stock was trading as low as 2.67, and saw subsequent high of 6.6497. A huge potential profit of 149% Since then, the stock has never dipped below that 2.67 mark, until yesterday, when disappointing third quarter and nine month financials were announced, and CETV was subject to a large backslide.

On stocks that see a large gap down, tanking the way CETV did, we watch closely for the establishment of a new base and following recovery. Especially when the sell-off seems to be a knee-jerk reaction to an earnings release. We won’t want to miss any potential rebound action on this one.

American Apparel, Inc. APP

APP earned us an honorable mention in yesterday’s Penny Stock Rumble for putting in a solid performance. The stock did just what we had hoped, making higher highs and higher lows, and preserving the current uptrend off of its bottom. The daily range was from 1.34-1.52, an intraday move of roughly 13.5% on more than twice the 3mo. average volume.

As we stated yesterday, this stock has been on our holiday retail watchlist for years now, and 2013 is no exception. We’ll be very interested to follow the activity on APP over the next several months.

Cyber Kiosk Solutions, Inc. CYBK

This is one we wanted to throw into the mix this morning after including on our watchlist yesterday. The company had some news out that caught our attention, and chart looks like it has some potential as well. Volume has recently been picking up, and the MACD is flipping up to the bullish side. The RSI recently passed the 50-line as well. We’re keeping CYBK on watch for a possible move as we head into week’s end.

CORAL SPRINGS, Fla., Oct. 29, 2013 /PRNewswire/ — Cyber Kiosk Solutions, Inc. (PINKSHEETS: CYBK) in May the Company announced 4,000 locations would be coming online using CYBK’s co-branded web based system.

These locations offer services such as, bill payment, money transfer, mobile top up, debit card load, gift card sales, Debit card purchase, and soon CYBK’s digital coupon program. >> FULL PR

Extended Watchlist:
EWSI, ANR, LSI, ARIA, CYNI (New lows watching for possible turnaround)

ONP, NQ, APP & Extended Watchlist

Orient Paper, Inc. ONP
–
ONP was a good pick from yesterday’s extended watchlist. We included it after after noticing that the stock was gapping up pre-market. It did so, and after touching a morning low of 2.15, we observed a move from ONP which took the price as high as 2.55. That was good for an intraday spike of 19%

This came on the heels of the company’s release of unaudited preliminary third quarter figures, which included 25% increases in both net income and earnings-per-share, and a 23.5% boost to gross profit. This is a steadily growing business that we will want to keep an eye on moving forward.

NQ Mobile, Inc. NQ

Another winner from the extended watchlist yesterday came in the form of NQ. The stock saw a daily range from 8.74 up to 12.18, and afforded us the opportunity at gains of up to 39% It seems we caught this play off of its bottom and mentioned it at just the right time.

As is generally the case when we come across such a play, today we’re on the lookout for the stock to post higher highs and higher lows to confirm an uptrend off of that bottom.

American Apparel, Inc. APP

On October 8th, we mentioned that we were watching for a bottom on an old favorite of ours, APP. It had been steadily downtrending since the beginning of August, and it seemed like the right time to re-alert the stock. Just two days later, we saw that bottom, as APP touched 1.04. After waiting patiently for just a few weeks, it seems that APP has finally begun a reversal and is now headed up once again. Yesterday APP broke through a key resistance point, the 50DMA at 1.31, and several indicators are showing strength, including the MACD, which is currently diverging, and we have an RSI which is heading straight into the power zone.

The timing here couldn’t much better, as APP has been one of our favorite retail stocks heading into the holiday season for years now. For example, last year, the stock saw a move from .90-2.40 between the months of November and April. The year before, it was from the .50-range up to 1.20. We are excited to see where this year’s retail season takes APP, especially after catching it right off of its dead bottom.

Extended Watchlist:
CYBK, S, NLST, ARIA, OXBT, MEET, BLDP

ATOS, CTIC, APP & Extended Watchlists

Atossa Genetics, Inc. ATOS

–
We tacked ATOS onto our extended watchlist yesterday morning, noting that the stock was in the midst of a “Huge gap down” and that we were “watching for a potential bounce”. Indeed that was the case, as the stock touched a low of 2.54 before a reversal carried it as high 3.18, a 25% intraday gain. As usual, when we see big gap-downs, we are looking out for quick-strike opportunities that allow us to make a rapid profit and a timely exit.We have uncovered a few other stocks fitting that profile that we will be monitoring for similar activity today:

Tower Group Intl. Ltd. TWGP

CEL-SCI Corp. CVM

Celgene Corp. CELGZ

Cell Therapeutics, Inc. CTIC
Another play from yesterday’s extended watchlist, CTIC opened at its low of day, and rumbled upward for a 23% move, closing at the high of day on nearly 12X its 3mo. average volume. In doing so, it managed to break a previous swing high at 1.80, a level we’d like to see hold as support moving forward.

We prepared the the following video chart on CTIC:

With the kind of momentum CTIC built up over the course of the day yesterday, this is one play that will be near the top of our watchlists in the near future. The catalyst here seems to be an agreement announced yesterday between the company and the FDA as outlined in the press release below.

SEATTLE, Oct. 7, 2013 /PRNewswire via COMTEX/ — Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced that the company reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the planned pivotal Phase 3 clinical trial, known as the PERSIST-2 trial, evaluating pacritinib compared to best available therapy, including approved JAK2 inhibitors such as ruxolitinib, in patients with myelofibrosis whose platelet counts are <100,000/uL. The SPA is a written agreement between CTI and the FDA regarding the design, endpoints and planned statistical analysis approach of the trial to be used in support of a potential New Drug Application (NDA) submission. The PERSIST-2 trial is the second of two planned Phase 3 clinical trials in patients with myelofibrosis. CTI expects to initiate the PERSIST-2 clinical trial in the fourth quarter of 2013. >>> FULL STORY

American Apparel, Inc. APP

APP is another stock we have tracked for an extended period of time. We have been watching this one to sniff out a bottom for the past few months, and wanted to re-enter it into the conversation today, as that point may be drawing near. A quick peek at the chart below clearly shows just that:

Extended Watchlist:

JCP, AGEN, CBMX, NAVB, TKMR

AAPL, CTXV & Extended Watchlist

Apple, Inc. AAPL – Options
Apple surpassed the $490-mark yesterday, as we suggested it might in Friday’s newsletter. Impressive iPhone sales seem to be the catalyst here as the stock gapped up yesterday and saw a daily high of 496.91, revealing the $480-$485 Calls that we were monitoring as multi-bag gainers.

To determine our next course of action, we are going to want to watch AAPL’s attitude closely; resistance at this point appears at $498 & $500. Failure to breach those levels could result in a consolidation for which we need to be prepared.

CTX Virtual Technologies, Inc. CTXV

We have CTXV on our long-term watchlist, and while the stock is fairly illiquid at this point in time, we like the idea and business plan behind this one enough to monitor its situation going forward.

CTX manufactures a variety of mobile communication technology including basic Cell Phones, PDA’s, Smartphone’s, Printed Circuit Boards and the worlds smallest fully-functioning PC, the MISEETX. CTX also manufactures and distributes it’s proprietary 3D electronic perception technology for interactive virtual computer keyboards.

In addition to logging almost $50M in net sales for the last reporting period, the company recently received the go-ahead from BlackBerry to begin using the BlackBerry compatible logo on their VK 200 Keyfob(TM) input devices.

MORE INFO @
http://www.ctxtechnologies.com

Extended Watchlist:
EXMT, APP, GOGO, DRYS